Homozygous familial hypercholesterolemia among French Canadians in Québec Province
- PMID: 2923577
- DOI: 10.1161/01.atv.9.2.211
Homozygous familial hypercholesterolemia among French Canadians in Québec Province
Abstract
Nineteen patients with homozygous familial hypercholesterolemia (FH) living at the time of the 1981 Canada census are the subject of this report. Their mean age at that time was 15, with a range of 1 to 26 years. All patients had extensive xanthomatosis but showed variable clinical manifestations of coronary heart disease (CHD); five (mean age, 21; range, 11 to 27 years) died from sudden death due to CHD. Plasma cholesterol levels varied more than twofold (557 to 1532 mg/dl). Variation in the concentrations of both plasma and low density lipoprotein cholesterol, as well as apolipoprotein B, were related neither to age at death from CHD nor to the clinical course of CHD. The mean high density lipoprotein cholesterol concentration (37 mg/dl) was lower than the mean value (49 mg/dl) in the control population (p less than 0.001). Both the clinical and biochemical features of this cohort are typical of homozygous FH. The prevalence of homozygotes among French Canadians in Québec was approximately 1:275,000, and the minimum estimated frequency of heterozygotes was 1:270. In northeastern Québec, the frequency of homozygotes was approximately 1:100,000, and the minimum estimated frequency of heterozygotes was 1:154. Only Afrikaaners in South Africa have correspondingly higher frequencies.
Similar articles
-
Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia.Atherosclerosis. 1993 Dec;104(1-2):153-8. doi: 10.1016/0021-9150(93)90186-x. Atherosclerosis. 1993. PMID: 8141839
-
Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.Pediatrics. 1995 Aug;96(2 Pt 1):239-46. Pediatrics. 1995. PMID: 7630677
-
Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations.Atherosclerosis. 1999 Mar;143(1):145-51. doi: 10.1016/s0021-9150(98)00267-6. Atherosclerosis. 1999. PMID: 10208489
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
-
Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".Am J Cardiol. 1993 Sep 30;72(10):6D-10D. doi: 10.1016/0002-9149(93)90003-u. Am J Cardiol. 1993. PMID: 8213499 Review.
Cited by
-
Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey.Clinicoecon Outcomes Res. 2013 May 3;5:189-92. doi: 10.2147/CEOR.S43087. Print 2013. Clinicoecon Outcomes Res. 2013. PMID: 23662069 Free PMC article.
-
Familial hypercholesterolemia in an Iranian family due to a mutation in the APOE gene (first case report).J Diabetes Metab Disord. 2022 Mar 10;21(1):1201-1205. doi: 10.1007/s40200-022-01007-1. eCollection 2022 Jun. J Diabetes Metab Disord. 2022. PMID: 35673444 Free PMC article.
-
DNA sampling and informed consent.CMAJ. 1991 Jan 15;144(2):128-9. CMAJ. 1991. PMID: 1986820 Free PMC article. No abstract available.
-
Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.Curr Genomics. 2013 Mar;14(1):25-32. doi: 10.2174/138920213804999200. Curr Genomics. 2013. PMID: 23997648 Free PMC article.
-
The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.Open Cardiovasc Med J. 2017 Jul 26;11:66-75. doi: 10.2174/1874192401711010066. eCollection 2017. Open Cardiovasc Med J. 2017. PMID: 28868092 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous